sibnayal
advicenne s.a. - potassium citrate monohydrated, potassium hydrogen carbonate - acidosis, renal tubular - mineral supplements - sibnayal is indicated for the treatment of distal renal tubular acidosis (drta) in adults, adolescents and children aged one year and older.
cardilan 0,175g/0,175g tableta
zentiva a.s., bratislava array - 4979 hemihydrÁt kalium-hydrogen-aspartÁtu; 4982 tetrahydrÁt magnesium-hydrogen-aspartÁtu - tableta - 0,175g/0,175g - draslÍk
kalium chloratum biomedica 500mg enterosolventní tableta
biomedica, spol. s r.o., praha array - 1174 chlorid draselnÝ - enterosolventní tableta - 500mg - chlorid draselnÝ
kalnormin 1g tableta s prodlouženým uvolňováním
bausch health ireland limited, dublin array - 1174 chlorid draselnÝ - tableta s prodlouženým uvolňováním - 1g - chlorid draselnÝ
pregabalin zentiva
zentiva, k.s. - pregabalin - anxiety disorders; epilepsy - antiepileptika, - neuropathic pain , pregabalin zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , epilepsy , pregabalin zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , generalised anxiety disorder , pregabalin zentiva is indicated for the treatment of generalised anxiety disorder (gad) in adults.
rivaroxaban viatris (previously rivaroxaban mylan)
mylan ireland limited - rivaroxaban - venous thromboembolism; pulmonary embolism; acute coronary syndrome; stroke; coronary artery disease; peripheral arterial disease; atrial fibrillation - antitrombotické činidla - rivaroxaban mylan co-administered with acetylsalicylic acid (asa) alone or with asa plus clopidogrel or ticlopidine, is indicated for the prevention of atherothrombotic events in adult patients after an acute coronary syndrome (acs) with elevated cardiac biomarkers. rivaroxaban mylan co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. ------prevention of venous thromboembolism (vte) in adult patients undergoing elective hip or knee replacement surgery. treatment of deep vein thrombosis (dvt) and pulmonary embolism (pe), and prevention of recurrent dvt and pe in adults. -------adults prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
pregabalin stada arzneimittel ag 150mg tvrdá tobolka
stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 150mg - pregabalin
pregabalin stada arzneimittel ag 75mg tvrdá tobolka
stada arzneimittel ag, bad vilbel array - 15519 pregabalin - tvrdá tobolka - 75mg - pregabalin
pregabalin vivanta 150mg tvrdá tobolka
vivanta generics s.r.o., praha array - 15519 pregabalin - tvrdá tobolka - 150mg - pregabalin
pregabalin vivanta 300mg tvrdá tobolka
vivanta generics s.r.o., praha array - 15519 pregabalin - tvrdá tobolka - 300mg - pregabalin